|
Additional narrative: complainant part is not expected to be returned for manufacturer review/investigation.The investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
It was reported that on (b)(6) 2021, patient underwent a surgical procedure for unknown reason.While completing tibial nail, the surgeon was removing the suprapatellar sleeve from the knee.It was noticed that a small piece was missing from the sleeve; it is unknown where the piece ended up.The surgery was successfully completed.There was no surgical delay reported.Fragments were generated.There was no patient consequence.This report is for a suprapatellar sleeve.This is report 1 of 1 for (b)(4).
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H3, h4, h6: manufacturing location: supplier ¿ (b)(4), packaged and released by: monument, release to warehouse date: 28-jun-2021, expiration date: 31-may-2023, part number: 03.010.437s, 12.0mm outer protection sleeve for suprapatellar - sterile, lot number: 87p6321 (sterile), lot quantity: (b)(4).Production order traveler met all inspection acceptance criteria.Certificate of analysis was reviewed and determined to be conforming.Inspection sheet, incoming final inspection met all inspection acceptance criteria.Packaging label log (pll) was reviewed and determined to be conforming.Packaging bom was reviewed and determined to be conforming with no deviations to normal packaging identified.Scn 20131 supplied by sterigenics was reviewed and determined to be conforming.This lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the inspection or release of the product that would contribute to this complaint condition.Product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|